According to Sun Pharmaceutical
's latest financial reports the company has $1.93 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-03-31 | $1.66 B | 28.17% |
2021-03-31 | $1.30 B | -10.26% |
2020-03-31 | $1.45 B | -9.89% |
2019-03-31 | $1.61 B | -25% |
2018-03-31 | $2.14 B | -9.39% |
2017-03-31 | $2.36 B | 6.94% |
2016-03-31 | $2.21 B | 5.6% |
2015-03-31 | $2.09 B | 30.94% |
2014-03-31 | $1.60 B | 62.15% |
2013-03-31 | $0.98 B | 0.72% |
2012-03-31 | $0.98 B | 99.53% |
2011-03-31 | $0.49 B | 262.76% |
2010-03-31 | $0.13 B | -58.75% |
2009-03-31 | $0.32 B | -2.04% |
2008-03-31 | $0.33 B | 4.94% |
2007-03-31 | $0.31 B | -7.1% |
2006-03-31 | $0.34 B | 27.08% |
2005-03-31 | $0.27 B | 1141.05% |
2004-03-31 | $21.81 M |